Mikroscan and QualityStar® Partner To Address Subspecialty Case Review In Community Pathology Practices
Enabling Economical Digital Pathology Transformation for Next-gen Diagnostic Accuracy in AP
San Diego, CA — October 25, 2016 — Mikroscan Technologies, Inc.
Mikroscan announced today it has entered into an agreement with QualityStar, LLC., a quality analytics and case review subscription service for Anatomic Pathology, to market its cloud-based and confidential case review to help reduce diagnostic interpretive errors and improve patient outcomes. Mikroscan delivers a suite of microscopy solutions to further help pathologists collaborate, consult, and communicate with other pathologists and providers anywhere in the world.
The partnership offers affordable, real-time microscopy, whole-slide imaging* solutions and access to a Pathology Consortium for subspecialty QA case review for community pathology practices – all through a monthly subscription based service model, removing the economic barrier for smaller practices.
The dual mode SL5 system from Mikroscan offers the user two completely separate and distinctly different capabilities in one convenient device. User selects either the live microscope mode using a fully functional, remotely controlled robotic microscope or a static digital pathology scanner for the creation of whole slide images* Mikroscan’s SL5 fits easily onto a desktop and requires minimal IT interface and user training. The SL5 is the most compact and cost-effective device in its class.
“We are pleased to support QualityStar’s quality assurance program, an excellent platform upon which to create an environment for continuous quality improvement through objective, independent expert assessment. Increasing caseloads and a steady declining global pathology workforce creates an immediate and growing need for affordable, versatile solutions addressing both organizational efficiency and quality. These shared values are the basis for our partnership with QualityStar” said Dr. Martin Stuart, Mikroscan’s President and CEO.
With the onset of MACRA in 2017, it is predicted that over 90% of community pathology practices remain unprepared to meet the needs of the rapidly changing healthcare landscape, which will demand measured quality and demonstrated diagnostic accuracy. Mikroscan’s live microscopy solutions and portability will provide the needed improvements for a more efficient and quality based operation.
Monique Spence, QualityStar’s President commented, “Pathology practices are faced with demands for efficiency in their services. The benefits of external case review by subspecialists, analytics to improve diagnostic proficiency and digital technology tools, enable a competitive advantage for better patient outcomes within the community they serve. This shift to outcome-based practices is compulsory for Anatomic Pathology.”
*For Research Use Only. Not for use in diagnostic procedures.
About Mikroscan® Technologies, Inc
Mikroscan provides affordable desktop microscopy and whole-slide imaging* solutions designed to promote the practice of pathology from a distance. Our mission is to distribute pathology expertise on demand, regardless of location, and in the process reduce healthcare costs and improve patient care. For more information about Mikroscan, please visit www.mikroscan.com.
About QualityStar®
QualityStar is a quality analytics and case review subscription service for Anatomic Pathology offering confidential third party quality assurance review with metrics to measure and continuously improve diagnostic proficiency. Approved by the American Board of Pathology (ABP) as a QA program for Part IV Maintenance of Certification, QualityStar draws on a national network of sub-specialists and serves as a low cost and impartial alternative to in-house quality assurance. QualityStar goes beyond the standard peer review concept – ultimately to help pathology practices reduce diagnostic interpretive errors and improve patient care. For more information, visit http://www.qualitystar.net/ or follow QualityStar on Linkedin and Twitter.
